Table 2.

Results of correlation between clinical pathologic characteristics including survival and expression of Sirtuin1

	Uterine cancer (n = 65)
	Median (± SD)	p
Histology		0.007
Endometrioid	4 (± 2.66)
Clear-cell	0 (± 2.01)
T-stage (Gr.)		0.267
T1	4 (± 2.46)
T2	4 (± 3.37)
T3	6 (± 3.70)
T4
pN		0.572
pN0	4 (± 2.25)
pN1	4 (± 2.64)
FIGO		0.161
I	4 (± 1.94)
II	4 (± 2.23)
III	6 (± 3.44)
IV	4 (± 2.58)
Grading		0.760
G1	4 (± 2.72)
G2	4 (± 3.01)
G3	4 (± 2.63)
Diabetes	–	0.858
Obesity	–	0.983
Hypertension	–	0.539
OS	–	0.07
PFS	–	0.042

OS overall survival, PFS progression-free survival, KW Kruskal–Wallis test

Significant results and important differences are shown in bold